Where has the time gone? We are now in 2024 and industry events are quickly approaching. If you are still gathering your thoughts on how best to maximise your time in 2024, allow us to flag the ‘must-attend’ Healthcare conferences of Winter/Spring 2024. January is for JPM The 42nd JPM Annual Healthcare Conference: 8th-11th January, San Francisco, […]
In October, at our 15th Annual Healthcare Investor Conference, we announced our chosen charity for the year, Ariana Smiles. Ariana Smiles is a Special Named Fund at the Children’s Cancer and Leukaemia Group, raising funds for research into precision oncology medicine for children with leukaemia. Stephanie Seales Gabbitas and her husband Chris set up Ariana […]
2023 was an exciting year for Optimum’s clients who overcame many of the market challenges to make significant strides forward with their vital life sciences research. Here are some of the highlights from what has been an exceptionally busy and successful year. M&A & deals Synaffix continued to build momentum – Lonza acquired the […]
Company on-track to dose first participant in multi-part, adaptive Phase 1, first-in-human study in healthy volunteers and Parkinson’s Disease (PD) patients in the first quarter of 2024 CTA comes as Nature Reviews Drug Discovery hails Mission’s mitophagy approach as “an appealing disease-modifying therapeutic strategy” for PD Cambridge, UK – 5 December 2023 – Mission Therapeutics (“Mission” […]
Replacing the lost function of the pancreas is the “holy grail” of treatments for type 1 diabetes, where the body becomes unable to produce the insulin it needs to regulate blood sugar levels. But the technology to do this has actually been around since the 1960s – it’s just been impractical to use on a […]
